| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292892 | Gastroenterology | 2012 | 9 Pages |
Abstract
PEG-IGD has high morbidity and mortality and is not associated with increased rates of virologic response. It is important to avoid PEG therapy in liver transplant recipients with specific clinical, biochemical, and histologic risk factors for PEG-IGD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Josh Levitsky, Maria Isabel Fiel, John P. Norvell, Edward Wang, Kymberly D. Watt, Michael P. Curry, Sumeet Tewani, Timothy M. McCashland, Maarouf A. Hoteit, Abraham Shaked, Samuel Saab, Amanda C. Chi, Amy Tien, Thomas D. Schiano,